Dexchlorpheniramine use while Breastfeeding
Drugs containing Dexchlorpheniramine: Vanacof, Rescon, Polaramine, DuraHist D, Resperal, SuTan, Rescon-Jr, Extendryl, Tanafed DMX, Deltuss DMX, Show all 49 »Deltuss DP, DexPhen M, AllerDur, Re-Drylex, CoryZa-D, Zotex HC, Codimal DH, Nalfrx, D-Hist D, Histatab D, Duotan PD, Hexafed, Notuss PD, Rescon-MX, NalDex, RhinaHist, Tanafed DP, Polaramine Expectorant, ProHist, P-Hist, Coryza-DM, TanaCof DM, Donatussin DM Suspension, Polaramine Repetabs, Corzall-PE, Vanacof CD, Dexphen w/C, Tannate DMP-DEX, C-Phed DPD Tann, Tannate PD-DM, Abatuss DMX, Hexaflu, EndaCof-Plus, SuTan-DM, TanDur DM, DuraTan Forte, Bromatan Plus, Dur-Tann Forte, Hydex PD
Dexchlorpheniramine Levels and Effects while Breastfeeding
Summary of Use during Lactation
Small, occasional doses of dexchlorpheniramine would not be expected to cause any adverse effects in breastfed infants. Larger doses or more prolonged use might cause effects in the infant or decrease the milk supply, particularly in combination with a sympathomimetic such as pseudoephedrine or before lactation is well established. Single bedtime doses after the last feeding of the day may be adequate for many women and will minimize any effects of the drug. The nonsedating antihistamines are preferred alternatives.
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information on dexchlorpheniramine was not found as of the revision date. In one telephone follow-up study, mothers reported irritability and colicky symptoms 10% of infants exposed to various antihistamines and drowsiness was reported in 1.6% of infants. None of the reactions required medical attention. In this study, no side effects were reported among 5 infants exposed to chlorpheniramine in breastmilk.
Possible Effects on Lactation
Dexchlorpheniramine in relatively high doses given by injection can decrease basal serum prolactin in nonlactating women and in early postpartum women. However, suckling-induced prolactin secretion is not affected by dexchlorpheniramine pretreatment of postpartum mothers. Whether lower oral doses of chlorpheniramine have the same effect on serum prolactin or whether the effects on prolactin have any consequences on breastfeeding success have not been studied. The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs to Consider
1. Ito S, Blajchman A, Stephenson M et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993;168:1393-9. PMID: 8498418
2. Messinis IE, Souvatzoglou A, Fais N et al. Histamine H1 receptor participation in the control of prolactin secretion in postpartum. J Endocrinol Invest. 1985;8:143-6. PMID: 3928731
3. Pontiroli AE, De Castro e Silva E, Mazzoleni F et al. The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: sex differences and the role of stress. J Clin Endocrinol Metab. 1981;52:924-8. PMID: 7228996
CAS Registry Number
LactMed Record Number
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.